← Evidence map

ArticleThe New England journal of medicine2020

Pembrolizumab for Early Triple-Negative Breast Cancer. Reply.

Peter Schmid et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32579835